3413-59-0 Usage
Uses
Used in Pharmaceutical Manufacturing:
(4-Butoxyphenyl)acetamide is used as an intermediate in the synthesis of various pharmaceutical products. Its unique structure and properties make it a valuable component in the development of new drugs and medicines.
Used in Organic Synthesis:
As a chemical compound with a butoxyphenyl group, (4-Butoxyphenyl)acetamide is utilized in organic synthesis for the production of a range of organic compounds. Its versatility in chemical reactions contributes to the creation of diverse organic molecules.
Used in Drug Development:
Due to its potential applications in medicine and research, (4-Butoxyphenyl)acetamide may be employed in the development of new drugs. Its chemical properties and structure can be leveraged to design and synthesize novel pharmaceutical agents with specific therapeutic effects.
Check Digit Verification of cas no
The CAS Registry Mumber 3413-59-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,4,1 and 3 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 3413-59:
(6*3)+(5*4)+(4*1)+(3*3)+(2*5)+(1*9)=70
70 % 10 = 0
So 3413-59-0 is a valid CAS Registry Number.
3413-59-0Relevant academic research and scientific papers
Design of Inhibitors from the Three-Dimensional Structure of Alcohol Dehydrogenase. Chemical Synthesis and Enzymatic Properties
Freudenreich, Charles,Samama, Jean-Pierre,Biellmann, Jean-Francois
, p. 3344 - 3353 (2007/10/02)
Inhibitors of liver alcohol dehydrogenase were designed from the three-dimensional structure of the enzyme.The ligand to the catalytic zinc ion is an amide group or, better, a formamide group.With the latter function, a hydrogen bond between the NH group and the hydroxyl group of Ser-48 may be formed.The hydrophobic substrate binding site brings structural restraints. α-ω bifunctional molecules show good inhibitory properties possibly due to the interactions with polar residues at the entrance of the substrate binding site.
